This study shows that LGR5+ compartments are present in liver cancer and exhibit characteristics of TICs/CSCs, such exhibit an improved ability to generate tumor organoids in culture and allografts in mice as well as resistance to standard anticancer therapy [82]. The gene discussed is LGR5; the disease is neoplasm.